Tags: Drug.

Sodelglitazar formerly known as GW 677954 is a thiazole PPARδ receptor agonist developed by GlaxoSmithKline. While it is primarily active at the PPARδ receptor it is considered a pan agonist with activity at PPARα and PPARγ receptors.

Sodelglitazar_skeletal.svg
CAS number
447406-78-2
IUPAC name
[4-[[[2-[2-Fluoro-4-(trifluoromethyl)phenyl]-4-methyl-13-thiazol-5-yl]methyl]sulfanyl]-2-methylphenoxy]-2-methylpropanoic acid

Loading...

This page contains content from the copyrighted Wikipedia article "Sodelglitazar"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.